Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Candesartan plus hydrochlorothiazide: an overview of its use and efficacy

Candesartan plus hydrochlorothiazide: an overview of its use and efficacy Introduction: The 2007 European Society of Cardiology/ European Society of Hypertension guidelines suggests that among the therapeutic possibilities, the use of angiotensin receptor blockers as an important component of antihypertensive combination therapy. Thiazide-type diuretics are usually added in order to increase the therapeutic efficacy in lowering blood pressure (BP). Many authors have demonstrated how effective is a fixed-dose combination of candesartan cilexetil/hydrochlorothiazide in lowering BP, even when compared with other antihypertensive drugs belonging to the same therapeutic category. Moreover, this combination showed good compliance and tolerability and few adverse reactions. Areas covered: The authors analyze the importance of the combination therapy of candesartan cilexetil plus hydrochlorothiazide in the treatment of hypertension. Many authors explain how effective BP control is often achieved only with the combination of drugs with different mechanisms of action, in particular in high risk patients or in those affected with diabetes mellitus or chronic renal disease; in fact, these patients need a more intensive BP control. Expert opinion: The fixed-dose combination drug candesartan/hydrochlorothiazide turned out to be a significant alternative in the treatment of hypertension, both for its high efficacy in BP reduction and in prevention of target organ damage, both for its tolerability and patient compliance. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Expert Opinion on Pharmacotherapy Taylor & Francis

Candesartan plus hydrochlorothiazide: an overview of its use and efficacy

11 pages

Loading next page...
 
/lp/taylor-francis/candesartan-plus-hydrochlorothiazide-an-overview-of-its-use-and-owHTpJDfyz

References (95)

Publisher
Taylor & Francis
Copyright
© Informa UK, Ltd.
ISSN
1744-7666
eISSN
1465-6566
DOI
10.1517/14656566.2012.745511
pmid
23170938
Publisher site
See Article on Publisher Site

Abstract

Introduction: The 2007 European Society of Cardiology/ European Society of Hypertension guidelines suggests that among the therapeutic possibilities, the use of angiotensin receptor blockers as an important component of antihypertensive combination therapy. Thiazide-type diuretics are usually added in order to increase the therapeutic efficacy in lowering blood pressure (BP). Many authors have demonstrated how effective is a fixed-dose combination of candesartan cilexetil/hydrochlorothiazide in lowering BP, even when compared with other antihypertensive drugs belonging to the same therapeutic category. Moreover, this combination showed good compliance and tolerability and few adverse reactions. Areas covered: The authors analyze the importance of the combination therapy of candesartan cilexetil plus hydrochlorothiazide in the treatment of hypertension. Many authors explain how effective BP control is often achieved only with the combination of drugs with different mechanisms of action, in particular in high risk patients or in those affected with diabetes mellitus or chronic renal disease; in fact, these patients need a more intensive BP control. Expert opinion: The fixed-dose combination drug candesartan/hydrochlorothiazide turned out to be a significant alternative in the treatment of hypertension, both for its high efficacy in BP reduction and in prevention of target organ damage, both for its tolerability and patient compliance.

Journal

Expert Opinion on PharmacotherapyTaylor & Francis

Published: Dec 1, 2012

Keywords: candesartan cilexetil; fixed-dose combination; hydrochlorothiazide; hypertension

There are no references for this article.